Dendrimers fascinating nanoparticles in the application in medicine

Size: px
Start display at page:

Download "Dendrimers fascinating nanoparticles in the application in medicine"

Transcription

1 Dendrimers fascinating nanoparticles in the application in medicine Małgorzata KUBIAK* Student Scientific Association FERMENT at Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Lodz, Poland Please cite as: CHEMIK 2014, 68, 2, A few words about the history of dendrimers The first information about the new class of branched molecules appeared in 1974 [1] in a publication written by a team of German chemist Fritz Vögtle, and because of their characteristic structure they were called an octopus molecules. A few years later, in 1978, the same group described the synthesis of these compounds, this time giving them a name cascade molecules [2]. However, they were not a typical dendrimers (Fig.1). The term dendrimer appeared for the first time in 1985 in the publication prepared by Donald Tomalia and co-workers. This name refers to their tree-like structure and is a combination of two Greek words dendron meaning tree and meros meaning part [3]. One year later the same team described the first of the two currently known ways of synthesis of this compound the divergent method, based on the attachment of a new monomers to the multifunctional core [4]. As a results of this research Tomalia obtained polyamidoamine (PAMAM) dendrimers, which are currently the best studied and, thanks to that, the best known molecules belonging to this group of compounds. At the same time, the group of Newkome synthesized the similar type of nanoparticles and called them arborols [5], but this name, which derives from Latin word arbor (also meaning tree), was not adopted. At first, these fascinating branched molecules did not draw special attention of the scientific community, but the situation changed with the development of nanotechnology. Fig. 1. Octopus molecule obtained by Vögtle s team At that time, the aim of synthesis of these highly branched molecules was obtaining particles, which would facilitate the dissolution of hydrophilic compounds in hydrophobic solvents. What are dendrimers? Dendrimers are highly branched, organic compounds with well-defined, symmetrical structure. From chemical point of view they are three-dimensional polymers, characterized by a globular shape. As depicted in Figure 3, in the central part of molecule is located a multifunctional core, from which emanate radially perfectly branched monomers, called dendrons. At the end of the arms are terminals, functional groups, which can be easily modified in order to change their chemical and physical properties. There are two types of dendrimer generation a full generation with hydroxyl or amine surface group and a half generation with carboxyl surface group. The last characteristic elements in the structure of dendrimers are internal cavities the empty spaces, which can be used as a pocket for different kind of small particles. Fig. 3. Schematic description of dendrimer structure Fig. 2. The structure of dendrimer PAMAM G3 Corresponding author: Małgorzata KUBIAK,, The structure of dendrimers has a significant impact on their chemical and physical properties and on their potential application. First of all, thanks to a large number of terminal functional groups, described polymers are characterized by unusually high reactivity. These features enable the attachment of various particles to the surface of dendrimers, e.g. drug substances, which are currently 146 nr 2/2014 tom 68

2 administered as a monomers. It was observed, that the compound itself exhibit a significantly weaker activity in comparisons with the equivalent amount of drug attached to dendrimer it is referred to as a dendrimeric effect [6]. Moreover, due to the presence of empty spaces between branches, they can be used to encapsulate smaller molecules. An important feature of described polymers is the facility of changing the nature of these compounds only by modification of terminal functional groups. However, the high cytotoxicity of some types of dendrimers cannot be ignored, because this feature limits their use in medicine. Synthesis of dendrimers Dendrimers are produced in iterative sequence of several reactions, each time leading to the creation of higher generation of polymer. Every new layer creates molecule with double number of active end groups and more than double molecular weight of the previous generation. One of the most appealing aspects of dendrimers is a possibility of precise control at every stage of synthesis, which allows to obtain a molecule with early designed, well-defined structure. Dendrimers can be made from any type of compounds, whose nature determines their solubility and biological activity. Most of the commonly encountered types in biological application are based on polyamidoamines, polyamines, polipeptydes, poliamides, polyesters, carbohydrates and nucleic acid. As mentioned earlier, the first applied method of dendrimer synthesis was the divergent method proposed by the Tomalia group. In this process described polymers grow outward by successive attaching a new layer of the monomers to a multifunctional core (Fig.4). Each reaction step results in an increase of molecule diameter, and arms become more and more branched. The last phenomenon is the reason of one of the most important disadvantage of this method congestion of the terminal functional groups with increased dendrimer generation, which results in loss of their reactivity. Furthermore, the post-reaction mixture consists a large number of molecules with various structural defects and with smaller than expected weight. To avoid these problems, a large excess of reagents (monomers) shall be used, however, this significantly increases the cost of synthesis and makes the purification of the final product more difficult. Fig. 4. Divergent method of dendrimer synthesis As a response to the weaknesses of the divergent method, in 1990 Hawker and Fréchet proposed a different way of dendrimer synthesis convergent method [7]. In this approach the first step is obtaining highly branched dendrons, which can be then connected to multifunctional core (Fig.5). The great advantage in this case is easier and more precise control of synthesis, and thanks to that, it is possible to obtain highly pure molecules, which are free from any defects. What is more, this method enables to design dendrimers, in which every dendrons are different. However, this is not an ideal way for producing describing polymers, because due to the steric effect it allows only for the synthesis of small molecule. Fig. 5. Convergent method of dendrimer synthesis It cannot be clearly determined which method is better, therefore, before the selection of one of them, many different factors should be taken into consideration (e.g. type of monomer or structure of dendrimer). Biomedical application of dendrimers Dendrimers, thanks to their unique feature, may in the future be applied in many various fields of science and industry. Currently, a fundamental limitation is the high cost of production of these compounds. A lot of attention is paid to the research on the use of these polymers in medicine, chemistry, genetic engineering and environmental protection. The first of these trends arouses the greatest interest due to the permanent demand for a new, better and more effective forms of therapy, especially, in the case of diseases, for which no cure has not yet been found. Studies on the dendrimer application in medicine can be divided into two major categories described molecules can be used as carrier for other substances or as therapeutic agent themselves. One of the first in vitro studies in this field was associated with the production of magnetic resonance imaging (MRI) contrast agent using dendrimers. Mostly used contrast agents are based on the complex of gadolinium ion (Gd 3+ ) and chelating ligand such as DOTA (1,4,7,10-tetraazacyclododecane tetraacetic acid) or DTPA (diethylenetriaminepentaacetic acid) [8, 9]. Chelators are required due to the high toxicity of free gadolinium ions it accumulates in human body including the liver, brain or bones [10, 11]. Described contrast agents are characterized by low molecular weight and therefore, they are removed too quickly from the body. The solution to this problem could be to conjugate gadolinium complexes with natural or synthetic polymers such as polysaccharides, proteins, polylysine [12]. These conjugates showed a better efficiency in imaging of tissues, however, this time they reminded in the body for too long, which might results in undesirable accumulation of gadolinium compound. In 1994 Wiener group proposed for the first time the use of PAMAM dendrimer as a carrier for the gadolinium complexes [13]. The results of these studies were so promising, that it drew the attention one of the pharmaceutical companies, Schering AG, whose product Gadomer 17 is currently in phase II clinical trials. Another extremely popular research direction arose from two unique structural features of dendrimers a large number of terminal groups and empty cavities between the arms. Thanks to these properties, described polymers may be used as drug carriers both on the surface of molecule and in its interior. Amidst numerous advantages of this application it should be mentioned the increase of effectiveness and elimination of side effects of cancer therapy, the possibility of controlled drug release, the solubility enhancement of hydrophobic compounds (as a carrier dendrimer with hydrophobic interior and hydrophilic surface) and in the distant future the opportunity to design the targeted therapy [14]. The exceptional ability of dendrimers to penetrate the cell membrane was the reason for starting the research on the use of them as a non-viral transfecting agent. Dendrimers with positively charged terminal groups (e.g. PAMAM) can easily bind to the negatively charged phosphate residues of nucleic acids. These complexes exhibit an increase stability and high transfection efficiency. The use of viral vectors carries some risk for the researcher, which can be avoided by applying dendrimer transection agents [15]. Another application of these nanoparticles is connected with their multivalency described feature may be used to create a new generation of vaccines. Presence of numerous functional groups on the surface of particles enables the attachment of multiple copies of both the identical and the different antigens, and therefore enhance the immunogenicity of the vaccines [6]. science technique nr 2/2014 tom

3 Summary of the most important application of dendrimers in medicine Biomedical application of dendrimers The advantages of using dendrimers Selected examples Magnetic resonance imaging (MRI) contrast agent Drug carrier: - particles encapsulated inside dendrimers - particles attached to the surface groups Dendrimers + active substances 1) Optimal circulation time within the body 2) Reduced risk of accumulations of gadolinium compounds 3) Good quality of imaging 1) Increase the solubility of hydrophobic drugs in aqueous environment of body fluids [25] 2) Increased cell membrane permeability for drugs 3) The protection of unstable drugs during the transport within the body 4) Controlled and prolonged release of drugs, and thereby reducing their toxicity 5) The possibility of lower dosage of the drugs 6) Minimizing the negative side effects of medicines [14] 7) The possibility of attachment of various active substances to one molecule of dendrimer [28] 8) The possibility of targeting the drug to certain tissues - targeted therapy [25] Gadomer 17 contrast agent containing gadolinium chelates based on polylysine dendrimers Table 1 Niclosamide antiparasitic drug, almost insoluble in water after encapsulation in PAMAM drendrimers increased solubility This also enabled the controlled drug released [26] Cisplatin popular anticancer drug thanks to the combination with PAMAM dendrimer it was possible to achieve slower release, lower toxicity, and also increased accumulation in tumor cells [27] Ketoprofen nonsteroidal anti-inflammatory drug the medicine was bound to the PAMAM dendrimer thereby obtained enhanced solubility in aqueous solution, an increase in its concentration in the blood, and prolonged effect of this drug [29] Gene therapy (non-viral transfection agents) 1) High efficiency of nucleic acids transport 2) Protection from degradation 3) High stability under the wide range of ph 4) Easy transfer of genes through the cell wall 5) Gene expression in vitro in various mammalian cell lines and in vivo in various animal tissues [30, 31, 32, 33] Dendrimer-oligonucleotide-plasmid complex tumor growth inhibitory factor. Plasmid contains a gene encoding tissue inhibitor of metalloproteinase or angiostatin (endogenous angiogenesis inhibitor) [34] SuperFect (Qiagen) commercially available transfection agent, based on PAMAM dendrimers [35, 36] Dendrimer-based vaccines 1) The ability to bind multiple copies of an antigen - increased immunogenicity of the vaccine 2) The possibility to omit protein carriers, which could be a potential sensitiser. Vaccine against malaria based on multiple antigenic peptide (MAP) dendrimers, currently in phase I clinical trials [6] Vaccines against HIV created using various kinds of dendrimers [37] Dendrimers per se Antiviral and antibacterial agents 1) The ability to block receptors on the surface of the virus 2) Prevention of the attachment of pathogens to mammalian cells either by strong adhesion to the bacterial cell wall and surface of the virus or by coating the potentially attacked cells. 3) The ability to destroy the negatively charged bacterial membrane, which results in the lysis of the cell [38, 29] Sialodendrimers inhibitors of hemagglutination process of human erythrocytes induced by influenza virus [17] VivaGel (Starpharma Ltd.) drug for women based on polylysine dendrimers (G4), protects against HIV infection. It works by blocking the receptors on the surface of the virus. Currently in phase III clinical trials [40] Treatment of neurodegenerative diseases (Alzheimer s, Parkinson s, prion) 1) Prevention of the formation of harmful amyloid deposits 2) The ability to destroy existing fibrillar protein aggregates PAMAM Denrimers G3, G4, G5 inhibitors of formation of amyloid plaques. They are also characterized by the ability to degrade the existing deposites [41] Anti-inflammatory agents 1) The ability to inhibit the synthesis of protein secreted during the induction of inflammatory response of the body 2) The ability to reduce existing inflammatory response 3) High solubility in water (compared with non-steroidal antiinflammatory drugs) Half-generation PAMAM dendrimers (G4.5) with functional groups conjugated with glucosamine the presence of these nanoparticles inhibits the secretion of proinflammatory chemokines and cytokines by LPS Phosphorus dendrimers covered with bisphosphonate (ABP) groups as above, additionally enhance the NK cell proliferation PAMAM dendrimers - exhibit anti-inflammatory activity in vivo in studies using models representing the two types of inflammation - acute and chronic Besides the use of dendrimers as a complex with other molecules, it is possible to apply them as an independent active substance. First of all, these nanoparticles show strong antibacterial and antiviral properties. Dendrimers may act in two ways: either by coating viruses and bacterial cells or by covering potentially attacked mammalian cells, thereby protecting from the infection [16]. One of the first studies in this area concerned the use of described nanoparticles against the influenza virus. For this purpose they applied sialic acid-conjugated dendrimers [17]. Described nanopolymers bind to the haemagglutinin present on the surface of the virus and thus prevent the adhesion of the pathogen to the cell. Another direction of research on the application of dendrimers per se is associated with attempts to use them in the treatment of neurodegenerative diseases such as Parkinson s 148 nr 2/2014 tom 68

4 disease, Alzheimer s disease or prion diseases. In all of cases the characteristic feature is the formation, and then the accumulation of amyloid deposits fibrillar aggregates built from proteins, which are normally dissolved. It turned out that dendrimers not only inhibit the formation of amyloid plaques, but also destroy the already existing [18, 19]. This direction seems to be particularly important, due to the fact that there are still no effective treatment methods for these diseases. Among the numerous studies on the properties of dendrimers in relation to their potential use in medicine, anti-inflammatory activity of these compounds is one of the most recent and promising discoveries in this field, therefor in this paper more attention was paid to this. Great interest in this subject is enhanced by an urgent need for a new, effective ways of treatment of autoimmune diseases such as rheumatoid arthritis, celiac disease, lupus or psoriasis. The first report mentioning the anti-inflammatory effects of dendrimers appeared in 2004, and its main topic was the prevention of scar tissue formation [20]. The research has been conducted using the half-generation PAMAM dendrimers (G4.5), in which a few of terminal carboxyl groups were conjugated with glucosamine. It turned out that despite the lipopolysaccharide (LPS, from Salmonella minnesota) stimulation, in the presence of these nanoparticles the immune cells did not produced neither proinflammatory chemokines nor cytokines proteins secreted during the induction of inflammatory response of the body. Another study, this time with the use of phosphorus dendrimers covered with bisphosphonate (ABP) groups, has led to the discovery of strong immunomodulatory and anti-inflammatory properties of these molecules [21, 22]. As in the previous example, they inhibited the release of pro-inflammatory proteins. It is worth mentioning, that the described dendrimers enhance the proliferation of natural killer (NK) cells [23], which are cytotoxic effectors against bacteria-, virus- or parasite-infected cells, and also against tumor cells what gives a chance to use them in cancer therapy. In 2009 the Tomalia group conducted in vivo studies on the use of PAMAM dendrimers as a potential carrier for indomethacin compound belongs to the group of non-steroidal anti-inflammatory drugs. Rats with induced inflammation were divided into three groups the first was treated with indomethacin alone, the second with complex of dendrimer and indomethacin and the third with dendrimer alone (it was intended to be a negative control). Unexpectedly, it turned out that the free PAMAM dendrimer showed anti-inflammatory activity, and what is even more interesting it was comparable to the effect induced by the complex of nanopolymer and indomethacin [24]. The most important biomedical applications, their advantages and selected examples are summarised in Table 1. Summary Dendrimers are polymers characterized by a unique structure from which derive their unique properties. In this study attention was drawn to the potential use of these compounds in medicine, however, it should be noted that all these examples are still in the phase of intensive research. Nevertheless, dendrimers give hope to create new methods for the treatment of diseases for which it have not yet be found a cure, such as neurodegenerative diseases or autoimmune diseases. Literature 1. Vögtle F., Weber E.: Octopus molecules. Angew. Chem. Int. Ed. 1974, 13, 12, Buhleier E., Wehner W., Vögtle F.: Cascade-chain-like and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis 1978, 2, Tomalia D.A., Baker H., Dewald J., Hall M., Kallos G., Martin S., Roeck J., Ryder J., Smith P.: A new class of polymers: starburst-dendritic macromolecules. Polym. J. 1985, 17, 1, Tomalia D.A., Baker H., Dewald J., Hall M., Kallos G., Martin S., Roeck J., Ryder J., Smith P.: Dendritic macromolecules: synthesis of starburst dendrimers. Macromolecules 1986, 19, 9, Newkome G.R., Yao Z., Baker G.R., Gupta V.K.: Cascade molecules: a new approach to micelles. A [27]-arborol. J. Org. Chem. 1985, 50, 11, Urbańczyk-Lipkowska Z.: Dendrymery w naukach biomedycznych. Gaz Farm 2008, 11, Hawker C.J., Frechet J.M.J.: Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J. Amer. Chem. Soc. 1990, 112, 21, Doubrovin M., Serganova I., Mayer-Kuckuk P., Ponomares V., Blasberg R.G.: Multimodality in vivo molecular-genetic imaging. Bioconjugate Chem. 2004, 15, 6, Caravan P., Ellison J.J., McMurry T.J, Lauffer R.B.: Gadolinium (III) chelates as MRI contrast agents: structure, dynamics and applications. Chem. Rev. 1999, 99, 9, Tweedle M.F., Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest. Radiol. 1992, 27, S2-S6 11. Franano F.N., Edwards W.B., Welch M.J., Brechbiel M.W., Gansow O.A. Duncan J.R.: Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo. Magn. Reson. Imaging 1995, 13, 2, Schuhmann-Giampieri G., Schmitt-Willich H., Frenzel T., Press W.R., Weinmann H.J.: In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest. Radiol. 1991, 26, 11, Wiener E.C., Brechbiel M.W., Brothers H., Magin R.L., Gansow O.A., Tomalia D.A., Lauterbur P.C.: Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 1994, 31, 1, Klajnert B., Bryszewska M.: Dendrimers in Medicine. Nova Science Publishers 2007, Sękowski S., Miłowska K., Gabryelak T.: Dendrymery w naukach biomedycznych i nanotechnologii. Post. Hig. 2008, 62, Klajnert B., Bryszewska M.: Dendrimers in Medicine. Nova Science Publishers 2007, Roy R., Zanini D., Meunier S.J., Romanowska A.: Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin. J. Chem. Soc., Chemical Communications 1993, 24, Supattapone S., Nguyen H-O.B., Cohen F.E., Prusiner S.B., Scott M.R.: Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. U S A 1999, 96, 25, Klajnert B., Cortijo-Arellano M., Cladera J., Majoral J.P., Caminade A.M., Bryszewska M.: Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP Biochem. Biophys. Res. Commun. 2007, 364, 1, Shaunak S., Thomas S., Gianasi E., Godwin A., Jones E., Teo I., Mireskandari K., Luthert P., Duncan R., Patterson S., Khaw P., Brocchini S.: Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat. Biotechnol. 2004, 22, 8, Caminade A.M., Turrin C.O., Majoral J.P.: Biological properties of phosphorus dendrimers. New J. Chem. 2010, 34, 8, Turrin C. O., Caminade A. M., Majoral J. P., Poupot M., Fournie J. J., Poupot R.: Immuno-modulations induced by phosphored dendrimers. Bull. Cancer. 2010, 97, S60-S Griffe L., Poupot M., Marchand P., Maraval A., Turrin C.O., Rolland O., Métivier P., Bacquet G., Fournié J.J., Caminade A.M., Poupot R., Majoral J.P.: Multiplication of human natural killer cells by nanosized phosphonatecapped dendrimers. Angew. Chem. Int. Ed. 2007, 46, 14, Chauhan A.S., Diwan P.V., Jain N.K., Tomalia D.A.: Unexpected in vivo antiinflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules 2009, 10, 5, Milhem O.M., Myles C., McKeown N.B., Attwood D., D Emanuele A.: Polyamidoamine Starburst dendrimers as solubility enhancers. Int. J. Pharm. 2000, 197, science technique nr 2/2014 tom

5 26. Devarakonda B., Hill R.A., Liebenberg W., Brits M., de Villiers M.M.: Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int. J. Pharm. 2005, 304, Malik N., Evagorou E.G., Duncan R.: Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 1999, 10, 8, Majoros I.J., Thomas T.P., Mehta C.B., Baker J.R. Jr: Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 2005, 48, 19, Na M., Yiyun C., Tongwen X., Yang D., Xiaomin W., Zhenwei L., Zhichao C., Guanyi H., Yunyu S., Longping W.: Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies. Eur. J. Med. Chem. 2006, 41, 5, Bielinska A., Kukowska-Latallo J.F., Johnson J., Tomalia D.A., Baker J.R. Jr.: Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 1996; 24, 11, Dufes C., Keith W.M., Proutski I., Bilsland A., Uchegbu I.F., Schätzlein A.G.: Synergistic anti-cancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res. 2005, 65, 18, Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Jr.: Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. U S A 1996, 93, Qin L., Pahud D.R., Ding Y., Bielinska A.U., Kukowska-Latallo J.F., Baker J.R.Jr., Bromberg J.S.: Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. Hum. Gene. Ther. 1998, 9, 4, Sato N., Kobayashi H., Saga T., Nakamoto Y., Ishimori T., Togashi K., Fujibayashi Y., Konishi J., Brechbiel M.W.: Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-dna complexed with dendrimers and/or avidin in mice. Clin. Cancer Res. 2001, 7, 11, Uchida E., Mizuguchi H., Ishii-Watabe A., Hayakawa T.: Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol. Pharm. Bull.2002, 25, 7, Leng Q., Mixson A.J.: Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection. Nucleic Acids Res. 2005, 33, 4, e Dzmitruk V., Shcharbin D., Pedziwiatr E., Bryszewska M.: Dendrimers in Anti-HIV Therapy. Advances in Nanocomposite Technology Boas U., Heegaard P.M.: Dendrimers in drug research. Chem. Soc. Rev. 2004, 33,1, Chen C.Z., Cooper S.L.: Interactions between dendrimer biocides and bacterial membranes. Biomaterials 2002, 23, 16, Price C.F,, Tyssen D., Sonza S., Davie A., Evans S., Lewis G.R., Xia S., Spelman T., Hodsman P., Moench T.R., Humberstone A., Paull J.R., Tachedjian G.: SPL7013 Gel (VivaGel ) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans. PLOS One 2011, 6, 9, e Klajnert B., Cortijo-Arellano M., Cladera J., Bryszewska M.: Influence of dendrimer s structure on its activity against amyloid fibril formation. Biochem. Biophys. Res. Commun. 2006, 345, 1, Translation into English by the Author * Małgorzata KUBIAK she graduated from the Faculty of Biotechnology and Food Sciences at Lodz University of Technology in November 2013 with an excellent result with Master s Degree in Biotechnology (specialization: Molecular Biotechnology and Technical Biochemistry). She is the author of 5 posters (2 at the international conferences and 3 at the national conferences). She has been a member of Scientific Association of Biotechnology Students FERMENT since October Spospoby finansowania B+R Methods of financing R&D dokończenie ze strony 145 CuBR Dyrektor Narodowego Centrum Badań i Rozwoju ogłasza I konkurs w ramach Porozumienia pomiędzy NCBR a KGHM Polska Miedź SA, dotyczącego Wspólnego Przedsięwzięcia o nazwie CuBR. Przedsięwzięcie jest ukierunkowane na poprawę efektywności procesu produkcyjnego, rozwój nowych technologii górniczych, nowe rozwiązania w zakresie systemów eksploatacji, skuteczne zarządzanie ryzykiem przemysłowym, a także rozwój bazy zasobowej, poprzez wydobycie zasobów głęboko zalegających. Konkurs skierowany jest do konsorcjów naukowych w rozumieniu ustawy o zasadach finansowania nauki, pod warunkiem, że w skład konsorcjum wchodzi przynajmniej jedna jednostka naukowa niebędąca przedsiębiorcą i co najmniej jeden przedsiębiorca albo co najmniej dwie jednostki naukowe. Nabór wniosków kończy się: 27 marca 2014 r. o godzinie 16:00. Ogłoszone w ramach I Konkursu tematy zawierają się w trzech obszarach tematycznych wskazanych w Założeniach Wspólnego Przedsięwzięcia CuBR. Obszar I Górnictwo i geologia Temat zagadnienia: Opracowanie innowacyjnej technologii udostępniania złoża głębokiego Obszar II Przeróbka (Mineral Processing) Temat zagadnienia: Innowacyjna technologia efektywnego rozdrabniania na potrzeby przygotowania rud metali nieżelaznych do wzbogacenia Obszar III Metalurgia, przetwórstwo, nowe materiały Temat zagadnienia: Opracowanie innowacyjnej hydrometalurgicznej technologii produkcji metali nieżelaznych z koncentratów KGHM Temat zagadnienia: Opracowanie innowacyjnego rozwiązania technologicznego do procesu odmiedziowania żużla w procesie zawiesinowego otrzymywania miedzi. Więcej na: https://cubr.ncbr.gov.pl/cubr/. (em) (http://www.ncbir.pl/ 16 luty 2014 r.) Optoelectronic components and systems for smart production,communication and medicine 27 stycznia 2014 r. Narodowe Centrum Badań i Rozwoju (NCBR) i Departament Gospodarki, Technologii i Badań Senatu Berlina (SenWTF) ogłosili otwarcie konkursu na wspólne projekty w dziedzinie fotoniki, w obszarze: Optoelectronic components and systems for smart production,communication and medicine. NCBR przeznacza kwotę EUR na dofinansowanie projektów polskich podmiotów, które zostaną zaakceptowane do finansowania w procedurze konkursowej. Termin składania wniosków upływa 31 marca 2014 r. (em) (http://www.ncbir.pl/ 16 luty 2014 r.) dokończenie na stronie nr 2/2014 tom 68

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

Hapten - a small molecule that is antigenic but not (by itself) immunogenic. Chapter 3. Antigens Terminology: Antigen: Substances that can be recognized by the surface antibody (B cells) or by the TCR (T cells) when associated with MHC molecules Immunogenicity VS Antigenicity:

More information

Chapter 18: Applications of Immunology

Chapter 18: Applications of Immunology Chapter 18: Applications of Immunology 1. Vaccinations 2. Monoclonal vs Polyclonal Ab 3. Diagnostic Immunology 1. Vaccinations What is Vaccination? A method of inducing artificial immunity by exposing

More information

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction

More information

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1 AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL

More information

Nanotechnology in Cancer Treatment and Detection. Richard Acosta

Nanotechnology in Cancer Treatment and Detection. Richard Acosta Nanotechnology in Cancer Treatment and Detection Richard Acosta Motivation Ineffectiveness of many Cancer treatments Numerous side effects Difficulties in early Cancer detection No immunization Scale and

More information

A Genetic Analysis of Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.

More information

Name (print) Name (signature) Period. (Total 30 points)

Name (print) Name (signature) Period. (Total 30 points) AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,

More information

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes

More information

Lymphatic System - Structures

Lymphatic System - Structures Lymphatic System - Structures Lymphatic vessels Lymphatic tissues and organs 1 Lymphatic System - Functions Returns leaked plasma to blood vessels Cleanses lymph of bacteria & other foreign matter Provides

More information

Carbohydrates, proteins and lipids

Carbohydrates, proteins and lipids Carbohydrates, proteins and lipids Chapter 3 MACROMOLECULES Macromolecules: polymers with molecular weights >1,000 Functional groups THE FOUR MACROMOLECULES IN LIFE Molecules in living organisms: proteins,

More information

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells. Transfection Key words: Transient transfection, Stable transfection, transfection methods, vector, plasmid, origin of replication, reporter gene/ protein, cloning site, promoter and enhancer, signal peptide,

More information

The Body s Defenses CHAPTER 24

The Body s Defenses CHAPTER 24 CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,

More information

What You Need to Know About Lung Cancer Immunotherapy

What You Need to Know About Lung Cancer Immunotherapy What You Need to Know About Lung Cancer Immunotherapy Lung.org/immunotherapy What is immunotherapy? Immunotherapy for cancer, sometimes called immune-oncology, is a type of medicine that treats cancer

More information

Immunotherapy Concept Turned Reality

Immunotherapy Concept Turned Reality Authored by: Jennifer Dolan Fox, PhD VirtualScopics Inc. jennifer_fox@virtualscopics.com +1 585 249 6231 Immunotherapy Concept Turned Reality Introduction While using the body s own immune system as a

More information

Chapter 17A: Adaptive Immunity Part I

Chapter 17A: Adaptive Immunity Part I Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive

More information

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors. Prof. Lester s BIOL 210 Practice Exam 4 (There is no answer key. Please do not email or ask me for answers.) Chapters 15, 16, 17, 19, HIV/AIDS, TB, Quorum Sensing 1) Siderophores are bacterial proteins

More information

Human Immunity. How our body s cells defend against microbial and viral invaders

Human Immunity. How our body s cells defend against microbial and viral invaders Human Immunity How our body s cells defend against microbial and viral invaders What is Immunity? The word immunity comes from the Latin immunus meaning free of burden. Thus; it is a body s general ability

More information

ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES

ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES DESCRIPTION OF GRANT MECHANISM The Alliance for Lupus Research (ALR) is an independent,

More information

Chapter 3 Molecules of Cells

Chapter 3 Molecules of Cells Bio 100 Molecules of cells 1 Chapter 3 Molecules of Cells Compounds containing carbon are called organic compounds Molecules such as methane that are only composed of carbon and hydrogen are called hydrocarbons

More information

Biological cell membranes

Biological cell membranes Unit 14: Cell biology. 14 2 Biological cell membranes The cell surface membrane surrounds the cell and acts as a barrier between the cell s contents and the environment. The cell membrane has multiple

More information

Modelling and analysis of T-cell epitope screening data.

Modelling and analysis of T-cell epitope screening data. Modelling and analysis of T-cell epitope screening data. Tim Beißbarth 2, Jason A. Tye-Din 1, Gordon K. Smyth 1, Robert P. Anderson 1 and Terence P. Speed 1 1 WEHI, 1G Royal Parade, Parkville, VIC 3050,

More information

STRUCTURE-GUIDED, FRAGMENT-BASED LEAD GENERATION FOR ONCOLOGY TARGETS

STRUCTURE-GUIDED, FRAGMENT-BASED LEAD GENERATION FOR ONCOLOGY TARGETS STRUCTURE-GUIDED, FRAGMENT-BASED LEAD GENERATION FOR ONCOLOGY TARGETS Stephen K. Burley Structural GenomiX, Inc. 10505 Roselle Street, San Diego, CA 92121 sburley@stromix.com www.stromix.com Summary Structural

More information

博 士 論 文 ( 要 約 ) A study on enzymatic synthesis of. stable cyclized peptides which. inhibit protein-protein interactions

博 士 論 文 ( 要 約 ) A study on enzymatic synthesis of. stable cyclized peptides which. inhibit protein-protein interactions 博 士 論 文 ( 要 約 ) 論 文 題 目 A study on enzymatic synthesis of stable cyclized peptides which inhibit protein-protein interactions ( 蛋 白 質 間 相 互 作 用 を 阻 害 する 安 定 な 環 状 化 ペプチドの 酵 素 合 成 に 関 する 研 究 ) 氏 名 張 静 1

More information

Basics of Immunology

Basics of Immunology Basics of Immunology 2 Basics of Immunology What is the immune system? Biological mechanism for identifying and destroying pathogens within a larger organism. Pathogens: agents that cause disease Bacteria,

More information

Managing Joint Venture Arrangements Between Two Biotech Companies: A Case Report. Dr. Jan Mous Midatech / PharMida May 21 st 2014

Managing Joint Venture Arrangements Between Two Biotech Companies: A Case Report. Dr. Jan Mous Midatech / PharMida May 21 st 2014 Managing Joint Venture Arrangements Between Two Biotech Companies: A Case Report Dr. Jan Mous Midatech / PharMida May 21 st 2014 1 Midatech Ltd. Corporate verview Founded 2000 in xford, England Drug development

More information

Anti-Inflammatory Drugs from Plant and Marine Sources

Anti-Inflammatory Drugs from Plant and Marine Sources D. A. Lewis Anti-Inflammatory Drugs from Plant and Marine Sources 1989 BirkhauserVerlag Basel Boston Berlin TABLE OF CONTENTS Page No. Preface. Acknowledgements..12 SECTION I : INFLAMMATION AND INFLAMMATORY

More information

Supplemental Material CBE Life Sciences Education. Su et al.

Supplemental Material CBE Life Sciences Education. Su et al. Supplemental Material CBE Life Sciences Education Su et al. APPENDIX Human Body's Immune System Test This test consists of 31 questions, with only 1 answer to be selected for each question. Please select

More information

Molecular Imaging and Prostate Cancer

Molecular Imaging and Prostate Cancer Molecular Imaging and Prostate Cancer Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. Based on rates from 2004 2006, the National Cancer Institute

More information

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope Viruses Chapter 10: Viruses Lecture Exam #3 Wednesday, November 22 nd (This lecture WILL be on Exam #3) Dr. Amy Rogers Office Hours: MW 9-10 AM Too small to see with a light microscope Visible with electron

More information

B Cells and Antibodies

B Cells and Antibodies B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production

More information

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types: Immune system. One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types: (pathogen - disease causing organism) 1) Non specific. Anything foreign

More information

Dendrimers in Cancer Treatment and Diagnosis

Dendrimers in Cancer Treatment and Diagnosis 1 1 Dendrimers in Cancer Treatment and Diagnosis Srinivasa-Gopalan Sampathkumar, and Kevin J. Yarema 1.1 Overview Dendrimers are nano-sized, radially symmetric molecules with well-defined, homogeneous

More information

CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS

CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS See APPENDIX (1) THE PRECIPITIN CURVE; (2) LABELING OF ANTIBODIES The defining characteristic of HUMORAL immune responses (which distinguishes them from CELL-MEDIATED

More information

BioMmune Technologies Inc. Corporate Presentation 2015

BioMmune Technologies Inc. Corporate Presentation 2015 BioMmune Technologies Inc Corporate Presentation 2015 * Harnessing the body s own immune system to fight cancer & other autoimmune diseases BioMmune Technologies Inc. (IMU) ABOUT A public biopharmaceutical

More information

Custom Antibody Services

Custom Antibody Services prosci-inc.com Custom Antibody Services High Performance Antibodies and More Broad Antibody Catalog Extensive Antibody Services CUSTOM ANTIBODY SERVICES Established in 1998, ProSci Incorporated is a leading

More information

INTRODUCTION TO HORMONES

INTRODUCTION TO HORMONES INTRODUCTION TO HORMONES UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ Temple What are hormones? Cells in multi-cellular

More information

2) Macrophages function to engulf and present antigen to other immune cells.

2) Macrophages function to engulf and present antigen to other immune cells. Immunology The immune system has specificity and memory. It specifically recognizes different antigens and has memory for these same antigens the next time they are encountered. The Cellular Components

More information

APPLICATION OF NANOPARTICLE IN CANCER TREATMENT

APPLICATION OF NANOPARTICLE IN CANCER TREATMENT APPLICATION OF NANOPARTICLE IN CANCER TREATMENT Introduction Nanotechnology is the design, characterization, production and application of structures, devices and systems by controlling shape and size

More information

8/20/2012 H C OH H R. Proteins

8/20/2012 H C OH H R. Proteins Proteins Rubisco monomer = amino acids 20 different amino acids polymer = polypeptide protein can be one or more polypeptide chains folded & bonded together large & complex 3-D shape hemoglobin Amino acids

More information

The Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.

The Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D. The Most Common Autoimmune Disease: Rheumatoid Arthritis Bonita S. Libman, M.D. Disclosures Two googled comics The Normal Immune System Network of cells and proteins that work together Goal: protect against

More information

Basic Overview of Preclinical Toxicology Animal Models

Basic Overview of Preclinical Toxicology Animal Models Basic Overview of Preclinical Toxicology Animal Models Charles D. Hebert, Ph.D., D.A.B.T. December 5, 2013 Outline Background In Vitro Toxicology In Vivo Toxicology Animal Models What is Toxicology? Background

More information

Combinatorial Chemistry and solid phase synthesis seminar and laboratory course

Combinatorial Chemistry and solid phase synthesis seminar and laboratory course Combinatorial Chemistry and solid phase synthesis seminar and laboratory course Topic 1: Principles of combinatorial chemistry 1. Introduction: Why Combinatorial Chemistry? Until recently, a common drug

More information

The application of nanotechnology in the treatment of Rheumatoid Arthritis and Osteoarthritis. By Aniketa Khushu PASS WITH MERIT

The application of nanotechnology in the treatment of Rheumatoid Arthritis and Osteoarthritis. By Aniketa Khushu PASS WITH MERIT The application of nanotechnology in the treatment of Rheumatoid Arthritis and Osteoarthritis By Aniketa Khushu PASS WITH MERIT Research Paper based on Pathology Lectures at Medlink 2010 1 Abstract: Introduction:

More information

Custom Antibodies & Recombinant Proteins

Custom Antibodies & Recombinant Proteins Custom Antibodies & Recombinant Proteins INTRODUCTION Custom services to meet your research and development requirements Improvements in health, medicine and diagnostics over the past century can be largely

More information

Absorption of Drugs. Transport of a drug from the GI tract

Absorption of Drugs. Transport of a drug from the GI tract Absorption of Drugs Absorption is the transfer of a drug from its site of administration to the bloodstream. The rate and efficiency of absorption depend on the route of administration. For IV delivery,

More information

Chapter 3. Immunity and how vaccines work

Chapter 3. Immunity and how vaccines work Chapter 3 Immunity and how vaccines work 3.1 Objectives: To understand and describe the immune system and how vaccines produce immunity To understand the differences between Passive and Active immunity

More information

Biology Content Standards

Biology Content Standards Biology Content Standards 1. The Chemistry of Life Broad Concept: Chemical elements form organic molecules that interact to perform the basic functions of life. 1.1 Recognize that biological organisms

More information

4. Which carbohydrate would you find as part of a molecule of RNA? a. Galactose b. Deoxyribose c. Ribose d. Glucose

4. Which carbohydrate would you find as part of a molecule of RNA? a. Galactose b. Deoxyribose c. Ribose d. Glucose 1. How is a polymer formed from multiple monomers? a. From the growth of the chain of carbon atoms b. By the removal of an OH group and a hydrogen atom c. By the addition of an OH group and a hydrogen

More information

The Molecules of Cells

The Molecules of Cells The Molecules of Cells I. Introduction A. Most of the world s population cannot digest milk-based foods. 1. These people are lactose intolerant because they lack the enzyme lactase. 2. This illustrates

More information

Test 4 Immune System (Chapters 20 & 21)

Test 4 Immune System (Chapters 20 & 21) Test 4 Immune System (Chapters 20 & 21) Name: Date: 1) The is the largest lymphoid organ. 1) A. lymph node B. spleen C. thymus D. tonsil 2) Tonsils promote memory of pathogens by. 2) A. secreting antibodies

More information

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells. Virus and Immune System Review Directions: Write your answers on a separate piece of paper. 1. Why does a cut in the skin threaten the body s nonspecific defenses against disease? a. If a cut bleeds, disease-fighting

More information

Chapter 2 Phosphorus in the Organic Life: Cells, Tissues, Organisms

Chapter 2 Phosphorus in the Organic Life: Cells, Tissues, Organisms Chapter 2 Phosphorus in the Organic Life: Cells, Tissues, Organisms As already mentioned (see Chap. 1 ), in the living cell phosphorus plays a decisive role in three different essential structures: In

More information

Making the switch to a safer CAR-T cell therapy

Making the switch to a safer CAR-T cell therapy Making the switch to a safer CAR-T cell therapy HaemaLogiX 2015 Technical Journal Club May 24 th 2016 Christina Müller - chimeric antigen receptor = CAR - CAR T cells are generated by lentiviral transduction

More information

Drug Development Services

Drug Development Services Drug Development Services USING BLOOD AND BONE MARROW PRIMARY CELL SYSTEMS Clinically Relevant In Vitro Assays Broad Spectrum of Drug Classes Multi-Species Platforms Enhancing Drug Development through

More information

Biotechnology. Srivatsan Kidambi, Ph.D.

Biotechnology. Srivatsan Kidambi, Ph.D. Stem Stem Cell Cell Engineering-What, Biology and it Application Why, How?? to Biotechnology Srivatsan Kidambi, Ph.D. Assistant Professor Department of Chemical & Biomolecular Engineering University of

More information

TREATING AUTOIMMUNE DISEASES WITH HOMEOPATHY. Dr. Stephen A. Messer, MSEd, ND, DHANP Professor and Chair of Homeopathic Medicine

TREATING AUTOIMMUNE DISEASES WITH HOMEOPATHY. Dr. Stephen A. Messer, MSEd, ND, DHANP Professor and Chair of Homeopathic Medicine TREATING AUTOIMMUNE DISEASES WITH HOMEOPATHY Dr. Stephen A. Messer, MSEd, ND, DHANP Professor and Chair of Homeopathic Medicine AUTOIMMUNE DISEASES An autoimmune disorder occurs when the body s immune

More information

The Need for a PARP in vivo Pharmacodynamic Assay

The Need for a PARP in vivo Pharmacodynamic Assay The Need for a PARP in vivo Pharmacodynamic Assay Jay George, Ph.D., Chief Scientific Officer, Trevigen, Inc., Gaithersburg, MD For further infomation, please contact: William Booth, Ph.D. Tel: +44 (0)1235

More information

What is nanotoxicology?

What is nanotoxicology? What is nanotoxicology? How to estimate the potential hazard related to nanoparticles? Dissemination report October 2008 DR-225 200810-5 Project ID NMP2-CT-2005-515843 An European Integrated Project Supported

More information

Microbiology AN INTRODUCTION EIGHTH EDITION

Microbiology AN INTRODUCTION EIGHTH EDITION TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein

More information

Advances in Biopharmaceutical and Vaccine Manufacturing Plants

Advances in Biopharmaceutical and Vaccine Manufacturing Plants Hitachi Review Vol. 62 (2013), No. 4 267 Advances in Biopharmaceutical and Vaccine Manufacturing Plants Sei Murakami, Dr. Eng. Haruo Suzuki Keisuke Shibuya, Dr. Sc. OVERVIEW: The development of innovative

More information

Chapter 43: The Immune System

Chapter 43: The Immune System Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2

More information

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line i 1 INTRODUCTION 1.1 Human Hepatitis B virus (HBV) 1 1.1.1 Pathogenesis of Hepatitis B 1 1.1.2 Genome organization of HBV 3 1.1.3 Structure of HBV virion 5 1.1.4 HBV life cycle 5 1.1.5 Experimental models

More information

ANATOMY OF THE IMMUNE SYSTEM THE IMMUNE SYSTEM. ANATOMY OF THE IMMUNE SYSTEM Thymus glandular organ near the heart where T cells learn their jobs

ANATOMY OF THE IMMUNE SYSTEM THE IMMUNE SYSTEM. ANATOMY OF THE IMMUNE SYSTEM Thymus glandular organ near the heart where T cells learn their jobs THE IMMUNE SYSTEM 1 ANATOMY OF THE IMMUNE SYSTEM 2 We all get sick sometimes...but then we get better. What happens when we get sick? Why do we get better? The immune system is localized in several parts

More information

KMS-Specialist & Customized Biosimilar Service

KMS-Specialist & Customized Biosimilar Service KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal

More information

Expression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu

Expression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu Expression and Purification of Recombinant Protein in bacteria and Yeast Presented By: Puspa pandey, Mohit sachdeva & Ming yu DNA Vectors Molecular carriers which carry fragments of DNA into host cell.

More information

Chapter 16: Innate Immunity

Chapter 16: Innate Immunity Chapter 16: Innate Immunity 1. Overview of Innate Immunity 2. Inflammation & Phagocytosis 3. Antimicrobial Substances 1. Overview of Innate Immunity The Body s Defenses The body has 2 types of defense

More information

Biological molecules:

Biological molecules: Biological molecules: All are organic (based on carbon). Monomers vs. polymers: Monomers refer to the subunits that, when polymerized, make up a larger polymer. Monomers may function on their own in some

More information

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA INTRODUCTION DNA : DNA is deoxyribose nucleic acid. It is made up of a base consisting of sugar, phosphate and one nitrogen base.the

More information

Viruses and Prokaryotes

Viruses and Prokaryotes Viruses and Prokaryotes Cellular Basis of Life Q: Are all microbes that make us sick made of living cells? 20.1 What is a virus? WHAT I KNOW SAMPLE ANSWER: A virus is a tiny particle that can make people

More information

I. Polymers & Macromolecules Figure 1: Polymers. Polymer: Macromolecule: Figure 2: Dehydration Synthesis

I. Polymers & Macromolecules Figure 1: Polymers. Polymer: Macromolecule: Figure 2: Dehydration Synthesis I. Polymers & Macromolecules Figure 1: Polymers Polymer: Macromolecule: Figure 2: Dehydration Synthesis 1 Dehydration Synthesis: Figure 3: Hydrolysis Hydrolysis: II. Organic Macromolecules Class I: Carbohydrates:

More information

Chapter 5: The Structure and Function of Large Biological Molecules

Chapter 5: The Structure and Function of Large Biological Molecules Name Period Concept 5.1 Macromolecules are polymers, built from monomers 1. The large molecules of all living things fall into just four main classes. Name them. 2. Circle the three classes that are called

More information

Safe Nano Design Molecule Manufacturing Market

Safe Nano Design Molecule Manufacturing Market August 14 16, 212 College of Nanoscale Science & Engineering (CNSE) of the University at Albany National Institute for Occupational Safety and Health (NIOSH) Prevention through Design Program Safe Nano

More information

Lecture Overview. Hydrogen Bonds. Special Properties of Water Molecules. Universal Solvent. ph Scale Illustrated. special properties of water

Lecture Overview. Hydrogen Bonds. Special Properties of Water Molecules. Universal Solvent. ph Scale Illustrated. special properties of water Lecture Overview special properties of water > water as a solvent > ph molecules of the cell > properties of carbon > carbohydrates > lipids > proteins > nucleic acids Hydrogen Bonds polarity of water

More information

Anatomy and Physiology Placement Exam 2 Practice with Answers at End!

Anatomy and Physiology Placement Exam 2 Practice with Answers at End! Anatomy and Physiology Placement Exam 2 Practice with Answers at End! General Chemical Principles 1. bonds are characterized by the sharing of electrons between the participating atoms. a. hydrogen b.

More information

Chemical Bonds and Groups - Part 1

Chemical Bonds and Groups - Part 1 hemical Bonds and Groups - Part 1 ARB SKELETS arbon has a unique role in the cell because of its ability to form strong covalent bonds with other carbon atoms. Thus carbon atoms can join to form chains.

More information

Your partner in immunology

Your partner in immunology Your partner in immunology Expertise Expertise Reactivity Reactivity Quality Quality Advice Advice Who are we? Specialist of antibody engineering Covalab is a French biotechnology company, specialised

More information

Chapter 20: Antimicrobial Drugs

Chapter 20: Antimicrobial Drugs Chapter 20: Antimicrobial Drugs 1. Overview of Antimicrobial Drugs 2. Antibacterial Drugs 3. Antiviral Drugs 4. Drugs for Eukaryotic Pathogens 1. Overview of Antimicrobial Drugs Antibiotics An antibiotic

More information

Type II. Antibody-mediated cytotoxic hypersensitivity

Type II. Antibody-mediated cytotoxic hypersensitivity Type II Antibody-mediated cytotoxic hypersensitivity The four types of hypersensitive responses Kuby J et al., Immunology 2003 Type II hypersensitivity reactions (1) - Caused by antibody to cell surface

More information

The Structure and Function of Macromolecules: Carbohydrates, Lipids & Phospholipids

The Structure and Function of Macromolecules: Carbohydrates, Lipids & Phospholipids The Structure and Function of Macromolecules: Carbohydrates, Lipids & Phospholipids The FOUR Classes of Large Biomolecules All living things are made up of four classes of large biological molecules: Carbohydrates

More information

Expectations for Data to Support Clinical Trial Drugs

Expectations for Data to Support Clinical Trial Drugs Expectations for Data to Support Clinical Trial Drugs Presentation to: APEC Advanced Workshop on Review of Drug Development in Clinical Trials Bangkok Thailand Feb 2-6 2009 Willem Stevens Ph.D., Chief

More information

Structure and Function of DNA

Structure and Function of DNA Structure and Function of DNA DNA and RNA Structure DNA and RNA are nucleic acids. They consist of chemical units called nucleotides. The nucleotides are joined by a sugar-phosphate backbone. The four

More information

Give a NOD to diabetes:

Give a NOD to diabetes: Give a NOD to diabetes: NOD proteins ti link immunity it and metabolism tbli Jonathan Schertzer McMaster University McMaster University Faculty of Health Sciences Department of Biochemistry and Biomedical

More information

Cancer Treatment Moringa Oleifera for Cancer Prevention or Treatment

Cancer Treatment Moringa Oleifera for Cancer Prevention or Treatment Cancer Treatment Moringa Oleifera for Cancer Prevention or Treatment As we learn more about cancer, we are empowered to use more of the tools which nature has created for us to help battle this terrible

More information

TECHNICAL INSIGHTS TECHNOLOGY ALERT

TECHNICAL INSIGHTS TECHNOLOGY ALERT TECHNICAL INSIGHTS TECHNOLOGY ALERT UNLOCKING BREAST CANCER TUMORS' DRUG RESISTANCE A troubling phenomenon in breast cancer treatment is that some patients tumors become resistant to treatments over time.

More information

No Disclosures. Learning Objectives 10/25/13

No Disclosures. Learning Objectives 10/25/13 No Disclosures Gregory A. Brent, MD Departments of Medicine and Physiology David Geffen School of Medicine at UCLA VA Greater Los Angeles Healthcare System Learning Objectives Describe the pathways that

More information

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères 91030 Evry Cedex. www.mabsolut.com. is involved at each stage of your project

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères 91030 Evry Cedex. www.mabsolut.com. is involved at each stage of your project Mabsolus-2015-UK:Mise en page 1 03/07/15 14:13 Page1 Services provider Department of MABSolys from conception to validation MAB Solut is involved at each stage of your project Creation of antibodies Production

More information

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein WLHS/A&P/Oppelt Name Lymphatic System Practice 1. Figure 12-1 provides an overview of the lymphatic vessels. First color code the following structures. Color code in Figure 12-1 Heart Veins Lymphatic vessels/lymph

More information

Non-clinical development of biologics

Non-clinical development of biologics Aurigon Life Science GmbH Non-clinical development of biologics Requirements, challenges and case studies Committed to Life. Sigrid Messemer vet. med. M4 Seminar March 10 th 2014 Aurigon - your full service

More information

the nature and importance of biomacromolecules in the chemistry of the cell: synthesis of biomacromolecules through the condensation reaction lipids

the nature and importance of biomacromolecules in the chemistry of the cell: synthesis of biomacromolecules through the condensation reaction lipids the nature and importance of biomacromolecules in the chemistry of the cell: synthesis of biomacromolecules through the condensation reaction lipids and their sub-units; the role of lipids in the plasma

More information

Nanotechnology Applications in Cancer Diagnosis and Therapy

Nanotechnology Applications in Cancer Diagnosis and Therapy Lecture XXVIII Nanotechnology Applications in Cancer Diagnosis and Therapy Abstract: Nanotechnology applications have reached exciting new area in science, with diverse applications in medicine. Nanotechnology

More information

Understanding the immune response to bacterial infections

Understanding the immune response to bacterial infections Understanding the immune response to bacterial infections A Ph.D. (SCIENCE) DISSERTATION SUBMITTED TO JADAVPUR UNIVERSITY SUSHIL KUMAR PATHAK DEPARTMENT OF CHEMISTRY BOSE INSTITUTE 2008 CONTENTS Page SUMMARY

More information

Quantum Molecular Design of Drugs

Quantum Molecular Design of Drugs Page1 W H I T E P A P E R Quantum Molecular Design of Drugs An In Silico Approach to Drug Discovery and Design in Novel Molecular Space Cloud Pharmaceuticals, Inc. 6 David Drive Research Triangle Park,

More information

Chapter 12 - Proteins

Chapter 12 - Proteins Roles of Biomolecules Carbohydrates Lipids Proteins 1) Catalytic 2) Transport 3) Regulatory 4) Structural 5) Contractile 6) Protective 7) Storage Nucleic Acids 12.1 -Amino Acids Chapter 12 - Proteins Amino

More information

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer

More information

Guidance for Industry Safety Testing of Drug Metabolites

Guidance for Industry Safety Testing of Drug Metabolites Guidance for Industry Safety Testing of Drug Metabolites U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) February 2008 Pharmacology

More information

2007 7.013 Problem Set 1 KEY

2007 7.013 Problem Set 1 KEY 2007 7.013 Problem Set 1 KEY Due before 5 PM on FRIDAY, February 16, 2007. Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. Where in a eukaryotic cell do you

More information

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia Pathogenesis of Dengue Natalia Taborda Vanegas Doc. Sci. Student Immunovirology Group Universidad de Antioquia Infection process Epidermis keratinocytes Dermis Archives of Medical Research 36 (2005) 425

More information

GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS -ii- GUIDELINES ON THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

Disaccharides consist of two monosaccharide monomers covalently linked by a glycosidic bond. They function in sugar transport.

Disaccharides consist of two monosaccharide monomers covalently linked by a glycosidic bond. They function in sugar transport. 1. The fundamental life processes of plants and animals depend on a variety of chemical reactions that occur in specialized areas of the organism s cells. As a basis for understanding this concept: 1.

More information